View in EDS HTML Full Text PDF Full Text

Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China.

Saved in:
Bibliographic Details
Title: Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China.
Authors: Qin X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Xiang T; Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, China., Zhang X; Department of Pulmonary and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou, China., Ma X; Department of Infectious Diseases, Beijing Tsinghua Changgung Hospital, Beijing, China., Zhao W; Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China., Yu Y; Department of Liver Diseases and Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China., Zhao C; Department of Infectious Diseases, The Third Hospital of Hebei Medical University, Shijiazhuang, China., Gao L; Department of Neurosurgery, Shanghai Tenth People's Hospital, Shanghai, China., Li L; Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Wang T; Department of Hematology, The Affiliated Hospital of Ningbo University Medical College, Ningbo, China., Pang C; Department of Infectious Diseases, Tianjin Medical University General Hospital, Heping, China., Zhao X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Han R; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Cao F; China Medical, Pfizer Inc, Beijing, China., Su M; China Medical, Pfizer Inc, Shanghai, China., Lu J; China Medical, Pfizer Inc, Shanghai, China., Xu W; China Medical, Pfizer Inc, Beijing, China., Yin S; China Medical, Pfizer Inc, Shanghai, China., Lu D; China Medical, Pfizer Inc, Shanghai, China., Yang X; China Medical, Pfizer Inc, Beijing, China., Wang M; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2026 Jan 27; Vol. 15, pp. 1663392. Date of Electronic Publication: 2026 Jan 27 (Print Publication: 2025).
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41675928
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Qin+X%22">Qin X</searchLink>; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xiang+T%22">Xiang T</searchLink>; Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Department of Pulmonary and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Department of Infectious Diseases, Beijing Tsinghua Changgung Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhao+W%22">Zhao W</searchLink>; Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China.<br /><searchLink fieldCode="AU" term="%22Yu+Y%22">Yu Y</searchLink>; Department of Liver Diseases and Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhao+C%22">Zhao C</searchLink>; Department of Infectious Diseases, The Third Hospital of Hebei Medical University, Shijiazhuang, China.<br /><searchLink fieldCode="AU" term="%22Gao+L%22">Gao L</searchLink>; Department of Neurosurgery, Shanghai Tenth People's Hospital, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+T%22">Wang T</searchLink>; Department of Hematology, The Affiliated Hospital of Ningbo University Medical College, Ningbo, China.<br /><searchLink fieldCode="AU" term="%22Pang+C%22">Pang C</searchLink>; Department of Infectious Diseases, Tianjin Medical University General Hospital, Heping, China.<br /><searchLink fieldCode="AU" term="%22Zhao+X%22">Zhao X</searchLink>; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Han+R%22">Han R</searchLink>; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Cao+F%22">Cao F</searchLink>; China Medical, Pfizer Inc, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Su+M%22">Su M</searchLink>; China Medical, Pfizer Inc, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; China Medical, Pfizer Inc, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xu+W%22">Xu W</searchLink>; China Medical, Pfizer Inc, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Yin+S%22">Yin S</searchLink>; China Medical, Pfizer Inc, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Lu+D%22">Lu D</searchLink>; China Medical, Pfizer Inc, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; China Medical, Pfizer Inc, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+M%22">Wang M</searchLink>; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101585359%22">Frontiers in cellular and infection microbiology</searchLink> [Front Cell Infect Microbiol] 2026 Jan 27; Vol. 15, pp. 1663392. <i>Date of Electronic Publication: </i>2026 Jan 27 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+SA%22">Frontiers Media SA </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101585359 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2235-2988 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222352988%22">22352988 </searchLink><i>NLM ISO Abbreviation: </i>Front Cell Infect Microbiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41675928
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fcimb.2025.1663392
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1663392
    Titles:
      – TitleFull: Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Qin X
      – PersonEntity:
          Name:
            NameFull: Xiang T
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Ma X
      – PersonEntity:
          Name:
            NameFull: Zhao W
      – PersonEntity:
          Name:
            NameFull: Yu Y
      – PersonEntity:
          Name:
            NameFull: Zhao C
      – PersonEntity:
          Name:
            NameFull: Gao L
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Wang T
      – PersonEntity:
          Name:
            NameFull: Pang C
      – PersonEntity:
          Name:
            NameFull: Zhao X
      – PersonEntity:
          Name:
            NameFull: Han R
      – PersonEntity:
          Name:
            NameFull: Cao F
      – PersonEntity:
          Name:
            NameFull: Su M
      – PersonEntity:
          Name:
            NameFull: Lu J
      – PersonEntity:
          Name:
            NameFull: Xu W
      – PersonEntity:
          Name:
            NameFull: Yin S
      – PersonEntity:
          Name:
            NameFull: Lu D
      – PersonEntity:
          Name:
            NameFull: Yang X
      – PersonEntity:
          Name:
            NameFull: Wang M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 01
              Text: 2026 Jan 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2235-2988
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in cellular and infection microbiology
              Type: main
ResultId 1